{"transactions":[{"id":746323,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2026-06-08T20:21:26.000Z","date":"2026-06-05","kind":"grant","planned":false,"acquired":true,"shares":4545,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the \"Plan\") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder."}],"balance_after":15343,"source":{"system":"sec-edgar","filing":"0001704317-26-000006","document":"wk-form4_1780950084.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802768/000170431726000006/wk-form4_1780950084.xml","form_type":"4"}},{"id":868355,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-03-03T23:04:29.000Z","date":"2026-02-27","kind":"grant","planned":false,"acquired":true,"shares":550000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on February 27, 2026, 2027, 2028 and 2029, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":550000,"derivative":{"exercise_price":11.52,"expiration_date":"2036-02-27","underlying":"Common Shares","underlying_shares":550000},"source":{"system":"sec-edgar","filing":"0001704317-26-000004","document":"wk-form4_1772579067.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431726000004/wk-form4_1772579067.xml","form_type":"4"}},{"id":917302,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-03","kind":"grant","planned":false,"acquired":true,"shares":51525,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"This option shall be fully vested and exercisable on February 3, 2027, the first anniversary of the vesting commencement date."}],"balance_after":51525,"derivative":{"exercise_price":17,"expiration_date":"2036-02-03","underlying":"Common Stock","underlying_shares":51525},"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917301,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":117112,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":117112},"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917300,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":78075,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vladimir Coric Marital Trust 2013."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":78075},"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917299,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":78075,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Vladimir Coric Family Trust 2013."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":78075},"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917298,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":148794,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vladimir Coric Marital Trust 2013."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":148794},"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917297,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":148794,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Vladimir Coric Family Trust 2013."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":148794},"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917296,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":33706,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vladimir Coric Marital Trust 2013."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33706},"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917295,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":false,"shares":33706,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Vladimir Coric Family Trust 2013."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":33706},"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917294,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":58823,"price":17,"value":999991.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vladimir Coric Marital Trust 2013."}],"balance_after":319398,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917293,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"purchase","planned":false,"acquired":true,"shares":58823,"price":17,"value":999991.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Vladimir Coric Family Trust 2013."}],"balance_after":319398,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917292,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":117112,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."}],"balance_after":129939,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917291,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":78075,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vladimir Coric Marital Trust 2013."}],"balance_after":260575,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917290,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":78075,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On February 5, 2026, the shares of Series C Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing  of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Vladimir Coric Family Trust 2013."}],"balance_after":260575,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917289,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":148794,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vladimir Coric Marital Trust 2013."}],"balance_after":182500,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917288,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":148794,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"On February 5, 2026, the shares of Series B Convertible Preferred Stock automatically converted into shares of Common Stock on a on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Vladimir Coric Family Trust 2013."}],"balance_after":182500,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917287,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":33706,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Shares held by Vladimir Coric Marital Trust 2013."}],"balance_after":33706,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":917286,"issuer":{"id":1907,"kind":"organization","name":"Veradermics, Inc","symbol":"MANE"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-02-06T00:04:25.000Z","date":"2026-02-05","kind":"exercise","planned":false,"acquired":true,"shares":33706,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 5, 2026, the shares of Series A Convertible Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.00001 per share (\"Common Stock\"), on a 10.067-for-1 basis without payment of further consideration immediately prior to the closing of the Issuer's initial public offering. The shares have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Shares held by Vladimir Coric Family Trust 2013."}],"balance_after":33706,"source":{"system":"sec-edgar","filing":"0001628280-26-005907","document":"wk-form4_1770336262.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1704317/000162828026005907/wk-form4_1770336262.xml","form_type":"4"}},{"id":944792,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Share Unit Award","published_at":"2026-01-08T02:32:31.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":false,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Not applicable."}],"balance_after":28500,"derivative":{"underlying":"Common Shares","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001704317-26-000002","document":"wk-form4_1767839548.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431726000002/wk-form4_1767839548.xml","form_type":"4"}},{"id":944791,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:32:31.000Z","date":"2026-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":7430,"price":9.93,"value":73779.9,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":1803968,"source":{"system":"sec-edgar","filing":"0001704317-26-000002","document":"wk-form4_1767839548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431726000002/wk-form4_1767839548.xml","form_type":"4"}},{"id":944790,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2026-01-08T02:32:31.000Z","date":"2026-01-05","kind":"exercise","planned":false,"acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1811398,"source":{"system":"sec-edgar","filing":"0001704317-26-000002","document":"wk-form4_1767839548.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431726000002/wk-form4_1767839548.xml","form_type":"4"}},{"id":997974,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-11-17T12:30:12.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":333333,"price":7.5,"value":2499997.5,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":740546,"source":{"system":"sec-edgar","filing":"0001704317-25-000004","document":"wk-form4_1763382609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431725000004/wk-form4_1763382609.xml","form_type":"4"}},{"id":997973,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-11-17T12:30:12.000Z","date":"2025-11-13","kind":"purchase","planned":false,"acquired":true,"shares":333333,"price":7.5,"value":2499997.5,"ownership":{"direct":false,"nature":"By: The Vlad Coric Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":1195275,"source":{"system":"sec-edgar","filing":"0001704317-25-000004","document":"wk-form4_1763382609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000170431725000004/wk-form4_1763382609.xml","form_type":"4"}},{"id":1149291,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-05-14T21:06:22.000Z","date":"2025-05-13","kind":"grant","planned":false,"acquired":true,"shares":7614,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the \"Plan\") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder."}],"balance_after":10798,"source":{"system":"sec-edgar","filing":"0001802768-25-000047","document":"wk-form4_1747256775.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802768/000180276825000047/wk-form4_1747256775.xml","form_type":"4"}},{"id":1168397,"issuer":{"id":3100,"kind":"organization","name":"Royalty Pharma plc","symbol":"RPRX"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A Ordinary Shares","published_at":"2025-04-21T21:43:06.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":3184,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the \"Plan\") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder."}],"balance_after":3184,"source":{"system":"sec-edgar","filing":"0001802768-25-000023","document":"wk-form4_1745271779.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1802768/000180276825000023/wk-form4_1745271779.xml","form_type":"4"}},{"id":1280275,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T15:49:44.000Z","date":"2025-02-06","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, each Issuer restricted stock award held by a non-employee member of the Issuer board then outstanding and not vested was canceled and converted into the right to receive the Per Share Price."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-25-015343","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000095017025015343/ownership.xml","form_type":"4"}},{"id":1280274,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-06T15:49:44.000Z","date":"2025-02-04","kind":"other","planned":false,"acquired":false,"shares":5784,"price":3.65,"value":21111.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The reported securities were disposed of pursuant to the terms of the Amended and Restated Agreement and Plan of Merger, dated as of December 7, 2024 (as subsequently amended, the \"Merger Agreement\"), by and among the Issuer, Crown Laboratories, Inc., a Delaware corporation (\"Parent\"), Reba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (\"Merger Sub,\" and together with Parent, the \"Buyer Parties\"), pursuant to which Merger Sub completed a cash tender offer (the \"Offer\") for all of the issued and outstanding shares of common stock, par value $0.001 per share (the \"Shares\"), of the Issuer at a purchase price of $3.65 per share, without interest, and subject to any applicable withholding taxes (the \"Per Share Price\"). These Issuer Shares were tendered for purchase pursuant to the Offer."}],"balance_after":15000,"source":{"system":"sec-edgar","filing":"0000950170-25-015343","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000095017025015343/ownership.xml","form_type":"4"}},{"id":1308340,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":false,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":42750,"derivative":{"underlying":"Common Shares","underlying_shares":14250},"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1308339,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Share Unit Award","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":57000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each restricted share unit represents the contingent right to receive one common share of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The reporting person was granted 57,000 restricted share units on January 5, 2025, vesting in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the reporting person's continued service with the Issuer at each vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Not applicable."}],"balance_after":57000,"derivative":{"underlying":"Common Shares","underlying_shares":57000},"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1308338,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"grant","planned":false,"acquired":true,"shares":343000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in four equal installments on January 5, 2025, 2026, 2027 and 2028, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":343000,"derivative":{"exercise_price":38.64,"expiration_date":"2035-01-05","underlying":"Common Shares","underlying_shares":343000},"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1308337,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":6805,"price":38.64,"value":262945.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"No shares were sold - these shares were withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted share units."}],"balance_after":1796604,"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1308336,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2025-01-08T01:48:39.000Z","date":"2025-01-05","kind":"exercise","planned":false,"acquired":true,"shares":14250,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":1803409,"source":{"system":"sec-edgar","filing":"0001935979-25-000002","document":"wk-form4_1736300913.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597925000002/wk-form4_1736300913.xml","form_type":"4"}},{"id":1392339,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-10-03T11:00:38.000Z","date":"2024-10-02","kind":"purchase","planned":false,"acquired":true,"shares":21052,"price":47.5,"value":999970.0,"ownership":{"direct":false,"nature":"By: The Vlad Coric Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":861942,"source":{"system":"sec-edgar","filing":"0001935979-24-000077","document":"wk-form4_1727953231.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000193597924000077/wk-form4_1727953231.xml","form_type":"4"}},{"id":1528113,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2024-05-03T08:43:48.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":23458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the earlier of (a) the one year anniversary, May 1, 2025 and (b) the day immediately prior to the date of the Company's next annual stockholder meeting, subject to the Director's Continuous Service through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":23458,"derivative":{"exercise_price":3.795,"expiration_date":"2034-04-30","underlying":"Common Stock","underlying_shares":23458},"source":{"system":"sec-edgar","filing":"0001479290-24-000085","document":"wk-form4_1714740220.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929024000085/wk-form4_1714740220.xml","form_type":"4"}},{"id":1528112,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-03T08:43:48.000Z","date":"2024-05-01","kind":"grant","planned":false,"acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Company's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\").  The shares underlying the RSA shall vest on the earlier of (a) the one year anniversary, May 1, 2025 and (b) the day immediately prior to the date of the Company's next annual stockholder meeting, subject to the Director's Continuous Service (as defined in the Company's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":20784,"source":{"system":"sec-edgar","filing":"0001479290-24-000085","document":"wk-form4_1714740220.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929024000085/wk-form4_1714740220.xml","form_type":"4"}},{"id":1536969,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-23T11:54:02.000Z","date":"2024-04-22","kind":"purchase","planned":false,"acquired":true,"shares":121951,"price":41,"value":4999991.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":1788417,"source":{"system":"sec-edgar","filing":"0001562180-24-003493","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003493/primarydocument.xml","form_type":"4"}},{"id":1546936,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-06T00:21:14.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":231,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":407213,"source":{"system":"sec-edgar","filing":"0001562180-24-003336","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003336/primarydocument.xml","form_type":"4"}},{"id":1546935,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-06T00:21:14.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":231,"ownership":{"direct":false,"nature":"By: The Vlad Coric Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":840890,"source":{"system":"sec-edgar","filing":"0001562180-24-003336","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003336/primarydocument.xml","form_type":"4"}},{"id":1546934,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-04-06T00:21:14.000Z","date":"2024-04-05","kind":"grant","planned":false,"acquired":true,"shares":232,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to merger transaction, consummated on January 8, 2024, 16,168 common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3.  The issuer subsequently determined that an error was made in the calculation of the number of common shares issued and on April 5, 2024, an additional 694 common shares of the Issuer were received by the Reporting Person related to the exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."}],"balance_after":1666466,"source":{"system":"sec-edgar","filing":"0001562180-24-003336","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024003336/primarydocument.xml","form_type":"4"}},{"id":1587186,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-08T23:35:28.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":2155,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":406982,"source":{"system":"sec-edgar","filing":"0001562180-24-002509","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024002509/primarydocument.xml","form_type":"4"}},{"id":1587185,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-08T23:35:28.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":2155,"ownership":{"direct":false,"nature":"By: The Vlad Coric Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":840659,"source":{"system":"sec-edgar","filing":"0001562180-24-002509","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024002509/primarydocument.xml","form_type":"4"}},{"id":1587184,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-03-08T23:35:28.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":2162,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to an agreement and plan of merger, dated as of January 7, 2024, common shares of the Issuer were issued to the Reporting Person on March 8, 2024.  The acquisition of the acquired company pursuant to the agreement and plan of merger and the issuance of common shares of the Issuer to the Reporting Person in connection therewith were approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"This balance includes 305 shares that were acquired through the Biohaven Employee Share Purchase Plan on May 31, 2023, and 1,336 shares that were acquired through the Biohaven Employee Share Purchase Plan on November 30, 2023."}],"balance_after":1666234,"source":{"system":"sec-edgar","filing":"0001562180-24-002509","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024002509/primarydocument.xml","form_type":"4"}},{"id":1681767,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-01-11T02:11:09.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":5384,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":404827,"source":{"system":"sec-edgar","filing":"0001562180-24-000426","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024000426/primarydocument.xml","form_type":"4"}},{"id":1681766,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-01-11T02:11:09.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":5384,"ownership":{"direct":false,"nature":"By: The Vlad Coric Family Trust"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These common shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":838504,"source":{"system":"sec-edgar","filing":"0001562180-24-000426","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024000426/primarydocument.xml","form_type":"4"}},{"id":1681765,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2024-01-11T02:11:09.000Z","date":"2024-01-08","kind":"grant","planned":false,"acquired":true,"shares":5400,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to a merger transaction, consummated on January 8, 2024, common shares of the Issuer were received by the Reporting Person in exchange for shares of common stock of the acquired company held by the Reporting Person in a transaction approved by the Board of the Issuer pursuant to Rule 16b-3."}],"balance_after":1662431,"source":{"system":"sec-edgar","filing":"0001562180-24-000426","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024000426/primarydocument.xml","form_type":"4"}},{"id":1688400,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-01-05T01:07:16.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on January 2, 2024, 2025, 2026 and 2027, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":275000,"derivative":{"exercise_price":41.93,"expiration_date":"2034-01-02","underlying":"Common Shares","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0001562180-24-000283","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218024000283/primarydocument.xml","form_type":"4"}},{"id":1748806,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-11-07T01:34:02.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":225000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in four equal installments on November 2, 2023, 2024, 2025, and 2026, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":225000,"derivative":{"exercise_price":29.49,"expiration_date":"2033-11-02","underlying":"Common Shares","underlying_shares":225000},"source":{"system":"sec-edgar","filing":"0001562180-23-007579","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023007579/primarydocument.xml","form_type":"4"}},{"id":1762789,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2023-10-10T11:17:13.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":113637,"price":22,"value":2500014.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":1657031,"source":{"system":"sec-edgar","filing":"0001562180-23-007246","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023007246/primarydocument.xml","form_type":"4"}},{"id":1762788,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Share","published_at":"2023-10-10T11:17:13.000Z","date":"2023-10-05","kind":"purchase","planned":false,"acquired":true,"shares":340908,"price":22,"value":7499976.0,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":833120,"source":{"system":"sec-edgar","filing":"0001562180-23-007246","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218023007246/primarydocument.xml","form_type":"4"}},{"id":1902647,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-05-05T17:14:10.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the earlier of (a) the one year anniversary, May 3, 2024 and (b) the day immediately prior to the date of the Company's next annual stockholder meeting, subject to Mr. Coric's Continuous Service through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":986,"derivative":{"exercise_price":33.61,"expiration_date":"2033-05-02","underlying":"Common Stock","underlying_shares":986},"source":{"system":"sec-edgar","filing":"0001479290-23-000059","document":"wf-form4_168332123696350.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929023000059/wf-form4_168332123696350.xml","form_type":"4"}},{"id":1902646,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-05T17:14:10.000Z","date":"2023-05-03","kind":"grant","planned":false,"acquired":true,"shares":589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Company's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\"). The shares underlying the RSA shall vest on the earlier of (a) the one year anniversary, May 3, 2024 and (b) the day immediately prior to the date of the Company's next annual stockholder meeting, subject to Mr. Coric's Continuous Service (as defined in the Company's 2014 Equity Incentive Plan (the \"Plan\")) through such vesting date."}],"balance_after":5784,"source":{"system":"sec-edgar","filing":"0001479290-23-000059","document":"wf-form4_168332123696350.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929023000059/wf-form4_168332123696350.xml","form_type":"4"}},{"id":1973214,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to buy)","published_at":"2023-03-03T16:32:31.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":8576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the stock option shall vest on the one year anniversary, subject to Mr. Coric's Continuous Service (as defined in the Plan) through such vesting date. The stock option represents an annual grant pursuant to the Compensation Policy."}],"balance_after":8576,"derivative":{"exercise_price":32.25,"exercise_date":"2024-03-01","expiration_date":"2033-02-28","underlying":"Common Stock","underlying_shares":8576},"source":{"system":"sec-edgar","filing":"0001479290-23-000033","document":"wf-form4_167787910428101.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929023000033/wf-form4_167787910428101.xml","form_type":"4"}},{"id":1973213,"issuer":{"id":83521,"kind":"organization","name":"Revance Therapeutics, Inc.","symbol":"RVNC"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-03-03T16:32:31.000Z","date":"2023-03-01","kind":"grant","acquired":true,"shares":5195,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an annual restricted stock award (the \"RSA\") granted pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy (the \"Compensation Policy\"). The shares underlying the RSA shall vest on the one year anniversary, March 1, 2024, subject to Mr. Coric's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan (the \"Plan\") through such vesting date."}],"balance_after":5195,"source":{"system":"sec-edgar","filing":"0001479290-23-000033","document":"wf-form4_167787910428101.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1479290/000147929023000033/wf-form4_167787910428101.xml","form_type":"4"}},{"id":2128673,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-01T11:34:07.000Z","date":"2022-10-31","kind":"purchase","acquired":true,"shares":25800,"price":15.9688,"value":411995.04,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $15.945 - $16.3024, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1543394,"source":{"system":"sec-edgar","filing":"0001562180-22-007386","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007386/primarydocument.xml","form_type":"4"}},{"id":2129728,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-31T11:52:51.000Z","date":"2022-10-28","kind":"purchase","acquired":true,"shares":100000,"price":14.8242,"value":1482420.0,"ownership":{"direct":false,"nature":"By: 401(K) Plan"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.659 - $14.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":109565,"source":{"system":"sec-edgar","filing":"0001562180-22-007373","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007373/primarydocument.xml","form_type":"4"}},{"id":2129727,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-31T11:52:51.000Z","date":"2022-10-28","kind":"purchase","acquired":true,"shares":41930,"price":14.8665,"value":623352.345,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $14.67 - $15.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."}],"balance_after":1517594,"source":{"system":"sec-edgar","filing":"0001562180-22-007373","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007373/primarydocument.xml","form_type":"4"}},{"id":2131755,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-26T22:22:10.000Z","date":"2022-10-25","kind":"purchase","acquired":true,"shares":853380,"price":10.5,"value":8960490.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares acquired in an underwritten public offering."}],"balance_after":1475664,"source":{"system":"sec-edgar","filing":"0001562180-22-007332","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007332/primarydocument.xml","form_type":"4"}},{"id":2138478,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-12T22:31:29.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":0,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Effective as of the pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. (\"RemainCo\") to holders of its common shares pursuant to the Separation and Distribution Agreement, dated as of May 9, 2022, by and among RemainCo, the Issuer and Pfizer Inc. (\"Pfizer\"), each outstanding restricted share unit of RemainCo was adjusted so that such restricted share unit became a restricted share unit in respect of Common Shares (each, an \"Issuer RSU\") and a restricted share unit in respect of RemainCo common shares. (Cont'd in FN2)"},{"field":"shares","element":"transactionShares","label":"F2","text":"(Cont'd from FN1) As a result, the Reporting Person acquired restricted share units in respect of Common Shares in an amount determined in accordance with the Separation Agreement. At the effective time of the merger of a wholly owned subsidiary of Pfizer (\"Merger Sub\") with and into RemainCo pursuant to the Agreement and Plan of Merger, dated as of May 9, 2022, by and among RemainCo, Pfizer and Merger Sub, the Issuer RSUs accelerated and vested in full and will subsequently be settled in Common Shares."},{"field":"shares","element":"transactionShares","label":"F3","text":"This amendment is being filed to correct the amount of shares beneficially owned reported in the Form 4 filed on October 5, 2022 (the \"Original Form 4\"). The Original Form 4 inadvertently incorrectly reported that 105,950 Issuer RSUs accelerated and vested in full and were subsequently settled in Common Shares; however, as reflected in this amendment, 52,975 Issuer RSUs accelerated and vested in full and were subsequently settled in Common Shares. There were no other changes made to the information in the Original Form 4."}],"balance_after":569309,"source":{"system":"sec-edgar","filing":"0001562180-22-007176","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007176/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-05"}},{"id":2141458,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":2100,"price":12.3467,"value":25928.07,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $12.34 - $12.39, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":399443,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2141457,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":52523,"price":11.7884,"value":619162.1332,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.32 - $12.28, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":397343,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2141456,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":80606,"price":10.8169,"value":871907.0414,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.32 - $11.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":344820,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2141455,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":34459,"price":9.8949,"value":340968.3591,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.31 - $10.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":264214,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2141454,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":73005,"price":8.8231,"value":644130.4155,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.30 - $9.29, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":229755,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2141453,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":54329,"price":11.8282,"value":642614.2778,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.32 - $12.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":492212,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2141452,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":80907,"price":10.8253,"value":875842.5471,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.32 - $11.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":437883,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2141451,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":34515,"price":9.9042,"value":341843.463,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $9.32 - $10.30, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":356976,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2141450,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T23:20:41.000Z","date":"2022-10-05","kind":"purchase","acquired":true,"shares":73331,"price":8.8234,"value":647028.7454,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Family Trust"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.27 - $9.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":322461,"source":{"system":"sec-edgar","filing":"0001562180-22-007115","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007115/primarydocument.xml","form_type":"4"}},{"id":2142594,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T01:40:29.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":9565,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: 401(K) Plan"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of the Issuer (\"Common Shares\") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the \"Original Form 4\"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired in the Distribution were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Common Shares acquired were indirectly held by the Reporting Person in the Vladimir Coric Family Trust, the Vladimir Coric Marital Trust, and the 401(K) Plan. There were no other changes made to the information in the Original Form 4."}],"balance_after":9565,"source":{"system":"sec-edgar","filing":"0001562180-22-007103","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007103/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-05"}},{"id":2142593,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T01:40:29.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":156750,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Marital Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of the Issuer (\"Common Shares\") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the \"Original Form 4\"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired in the Distribution were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Common Shares acquired were indirectly held by the Reporting Person in the Vladimir Coric Family Trust, the Vladimir Coric Marital Trust, and the 401(K) Plan. There were no other changes made to the information in the Original Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":156750,"source":{"system":"sec-edgar","filing":"0001562180-22-007103","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007103/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-05"}},{"id":2142592,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T01:40:29.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":249130,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By: The Vladimir Coric Family Trust"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of the Issuer (\"Common Shares\") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the \"Original Form 4\"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired in the Distribution were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Common Shares acquired were indirectly held by the Reporting Person in the Vladimir Coric Family Trust, the Vladimir Coric Marital Trust, and the 401(K) Plan. There were no other changes made to the information in the Original Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"These Common Shares are held in a trust for the benefit of the Reporting Person's family members, excluding the Reporting Person. The Reporting Person's spouse is trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, and the inclusion of the securities held by the trust in this report and prior Section 16 filings by the Reporting Person is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose."}],"balance_after":249130,"source":{"system":"sec-edgar","filing":"0001562180-22-007103","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007103/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-05"}},{"id":2142591,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Shares","published_at":"2022-10-06T01:40:29.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":46025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents common shares of the Issuer (\"Common Shares\") acquired by the Reporting Person in a pro rata distribution by Biohaven Pharmaceutical Holding Company Ltd. (\"RemainCo\") to holders of its common shares (the \"Distribution\") pursuant to the Separation and Distribution Agreement (the \"Separation Agreement\"), dated as of May 9, 2022, by and among RemainCo, the Issuer, and Pfizer Inc. (\"Pfizer\")."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"This amendment is being filed to correct the form of ownership reported in the Form 4 filed on October 5, 2022 (the \"Original Form 4\"). The Original Form 4 inadvertently incorrectly reported that all Common Shares acquired in the Distribution were directly held by the Reporting Person; however, as reflected in this amendment, a portion of the Common Shares acquired were indirectly held by the Reporting Person in the Vladimir Coric Family Trust, the Vladimir Coric Marital Trust, and the 401(K) Plan. There were no other changes made to the information in the Original Form 4."}],"balance_after":622284,"source":{"system":"sec-edgar","filing":"0001562180-22-007103","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007103/primarydocument.xml","form_type":"4/A","original_submission_date":"2022-10-05"}},{"id":2142473,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"grant","acquired":true,"shares":950000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The shares underlying this option vest in four equal installments on October 3, 2022, 2023, 2024, and 2025, subject to the Reporting Person's continuous service with the Issuer at each vesting date."}],"balance_after":950000,"derivative":{"exercise_price":7,"expiration_date":"2032-10-04","underlying":"Common Shares","underlying_shares":950000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":54,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142472,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":125000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-25","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":53,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142471,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":37500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":0.28,"expiration_date":"2025-10-22","underlying":"Common Shares","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":52,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142470,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":0.28,"expiration_date":"2025-10-22","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":51,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142469,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":0.46,"expiration_date":"2026-12-14","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":50,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142468,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":0.54,"expiration_date":"2027-04-05","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":49,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142467,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":90380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2027-12-06","underlying":"Common Shares","underlying_shares":90380},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":48,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142466,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":9620,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.03,"expiration_date":"2027-12-06","underlying":"Common Shares","underlying_shares":9620},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":47,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142465,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":1542,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.61,"expiration_date":"2028-11-20","underlying":"Common Shares","underlying_shares":1542},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":46,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142464,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":98458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":1.61,"expiration_date":"2028-11-20","underlying":"Common Shares","underlying_shares":98458},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":45,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142463,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":43750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":2.84,"expiration_date":"2029-11-25","underlying":"Common Shares","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":44,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142462,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":48801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":4.13,"expiration_date":"2031-01-06","underlying":"Common Shares","underlying_shares":48801},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":43,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142461,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":1199,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":4.13,"expiration_date":"2031-01-06","underlying":"Common Shares","underlying_shares":1199},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":42,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142460,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":34612,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":6.37,"expiration_date":"2032-01-07","underlying":"Common Shares","underlying_shares":34612},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":41,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142459,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"exercise","acquired":false,"shares":387,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":0,"derivative":{"exercise_price":6.37,"expiration_date":"2032-01-07","underlying":"Common Shares","underlying_shares":387},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":40,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142458,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":125000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":125000,"derivative":{"exercise_price":0.04,"expiration_date":"2024-11-25","underlying":"Common Shares","underlying_shares":125000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":39,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142457,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":37500,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":37500,"derivative":{"exercise_price":0.28,"expiration_date":"2025-10-22","underlying":"Common Shares","underlying_shares":37500},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":38,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142456,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":50000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":50000,"derivative":{"exercise_price":0.28,"expiration_date":"2025-10-22","underlying":"Common Shares","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":37,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142455,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":25000,"derivative":{"exercise_price":0.46,"expiration_date":"2026-12-14","underlying":"Common Shares","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":36,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142454,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":20000,"derivative":{"exercise_price":0.54,"expiration_date":"2027-04-05","underlying":"Common Shares","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":35,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142453,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":90380,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":90380,"derivative":{"exercise_price":1.03,"expiration_date":"2027-12-06","underlying":"Common Shares","underlying_shares":90380},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":34,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142452,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":9620,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":9620,"derivative":{"exercise_price":1.03,"expiration_date":"2027-12-06","underlying":"Common Shares","underlying_shares":9620},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":33,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142451,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":1542,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":1542,"derivative":{"exercise_price":1.61,"expiration_date":"2028-11-20","underlying":"Common Shares","underlying_shares":1542},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":32,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142450,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":98458,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":98458,"derivative":{"exercise_price":1.61,"expiration_date":"2028-11-20","underlying":"Common Shares","underlying_shares":98458},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":31,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142449,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":43750,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":43750,"derivative":{"exercise_price":2.84,"expiration_date":"2029-11-25","underlying":"Common Shares","underlying_shares":43750},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":30,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142448,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":48801,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":48801,"derivative":{"exercise_price":4.13,"expiration_date":"2031-01-06","underlying":"Common Shares","underlying_shares":48801},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":29,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142447,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":1199,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":1199,"derivative":{"exercise_price":4.13,"expiration_date":"2031-01-06","underlying":"Common Shares","underlying_shares":1199},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":28,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}},{"id":2142446,"issuer":{"id":4379,"kind":"organization","name":"Biohaven Ltd.","symbol":"BHVN"},"owners":[{"id":40505,"kind":"person","name":"Coric Vlad","position":1,"cik":"0001704317","reported_name":"Coric Vlad","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-10-05T21:33:50.000Z","date":"2022-10-03","kind":"other","acquired":true,"shares":34612,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"shares","element":"transactionShares","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Effective as of the Distribution, each outstanding option to purchase common shares of RemainCo was adjusted so that such option became an option to acquire Common Shares and an option to acquire RemainCo common shares. As a result, the Reporting Person acquired options to acquire the Issuer's Common Shares in an amount determined in accordance with the Separation Agreement."}],"balance_after":34612,"derivative":{"exercise_price":6.37,"expiration_date":"2032-01-07","underlying":"Common Shares","underlying_shares":34612},"source":{"system":"sec-edgar","filing":"0001562180-22-007074","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":27,"url":"https://www.sec.gov/Archives/edgar/data/1935979/000156218022007074/primarydocument.xml","form_type":"4"}}],"next_cursor":"2022-10-05T21:33:50.000000Z,2142446"}